Middle East And Africa Insulin Delivery Devices Market Size (2024 - 2029)

Middle East And Africa Insulin Delivery Devices Market Analysis

The Middle East And Africa Insulin Delivery Devices Market size is estimated at USD 1.96 billion in 2024, and is expected to reach USD 2.27 billion by 2029, growing at a CAGR of 2.99% during the forecast period (2024-2029).

An insulin infusion pump works as an alternative to the traditional system of daily injections or an insulin pen. Insulin infusion pumps reduce the large swings in blood glucose levels, lessen pain, and deliver more accurately than injections. The scheduling of meal timings is not required when using pumps. This makes infusion pumps more user-friendly for patients. Insulin therapy is also known as continuous subcutaneous insulin infusion (CSII). It is an efficient and flexible method of insulin delivery.

The advancement of technology has greatly enhanced the effectiveness of insulin delivery devices, resulting in improved management of glucose levels. Despite this progress, a majority of individuals who require insulin still rely on traditional methods such as syringes or traditional pens. Engaging in a conversation with your healthcare provider regarding these modern devices could greatly simplify the process of administering insulin.

In recent decades, technological advancements and innovative solutions have paved the way for a variety of insulin delivery devices, aiming to alleviate the difficulties and burdens associated with insulin administration. These devices range from simple patches to automated insulin delivery (AID) systems. However, it is noteworthy that a significant portion of insulin users still opt for the traditional combination of insulin bottles, syringes, or conventional insulin pens.

Technological advancements have increased over the period in Insulin delivery devices for safer and more accurate administration of insulin. Medtronic launched an Extended infusion set that leverages advanced materials that help reduce insulin preservative loss and maintains insulin flow and stability. The set is compatible with all MiniMed 600 and 700 series insulin pumps. The new tubing connector improves the physical and chemical stability of insulin, reliability of infusion site performance, and reduces the risk of infusion set occlusion. In addition to the new infusion set, the Medtronic Extended reservoir is also tested and approved to keep insulin stable and safely used for up to 7 days.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Middle East And Africa Insulin Delivery Devices Industry Segmentation

There are different ways to inject insulin into a patient's body using syringes, pens, pumps, and jet injectors, giving them various options for insulin delivery. The Middle East and Africa insulin delivery devices market is segmented into type and geography. The report offers the value (in USD) and volume (in units) for the above segments.